Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
alnylam pharmaceuticals
4
×
boston blog main
clinical trials
life sciences
national blog main
new york blog main
new york top stories
4
×
amgen
biotech
inclisiran
national top stories
new york
pcsk9 inhibitors
regeneron pharmaceuticals
alirocumab
boston top stories
deals
evolocumab
fda
novartis
rna interference
sanofi
abbvie
akouos
allergan
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
cholesterol
covid-19
crispr
deerfield management
What
medicines
4
×
cholesterol
drug
medco
deal
fda
lowering
new
acquire
acquisitions
agreed
alnylam
announced
based
billion
bio
bringing
brings
cash
ceo
clears
closer
collabs
company
compound
covid
daniel
data
evidence
filing
gilead
gilead’s
heart
help
inched
introduce
ipo
lasting
long
looms
Language
unset
Current search:
medicines
×
photo
×
" alnylam pharmaceuticals "
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms